An AI Model Can Help Predict Adverse Events From New Drug Combinations
NEW ORLEANS – Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new combination...
NEW ORLEANS – Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new combination...
NEW ORLEANS – The accuracy of prostate-specific antigen (PSA) screening for prostate cancer could be improved by accounting for...
NEW ORLEANS – During the first nine months of the COVID-19 pandemic, pediatric cancer patients from lower- and middle-income...
NEW ORLEANS – In its first year of implementation, the RACE Act has resulted in increased requirements for more...
NEW ORLEANS – A variant of the CTLA-4 gene associated with autoimmune disease was found to be more frequent...
An mRNA vaccine was combined with CAR T cells that target tumor cells expressing the CLDN6 antigen NEW ORLEANS...
Patients with recurrent lesions genetically distinct from the primary tumor may require different treatment NEW ORLEANS – More than...
NEW ORLEANS – Natural killer (NK) cells derived from cord blood that were activated and complexed with a CD30/CD16A...
Two-year follow up of the CodeBreaK 100 clinical trial demonstrated prolonged tumor responses and a favorable safety profile NEW...
NEW ORLEANS – Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new combination...